|
EP0043272B1
(en)
*
|
1980-07-01 |
1984-06-13 |
National Research Development Corporation |
Production of viral antigens
|
|
DE3235924T1
(de)
*
|
1981-03-06 |
1983-05-05 |
Celltech Ltd., Slough, Berkshire |
Monoklonaler antikoerper
|
|
EP0092918B1
(en)
*
|
1982-04-22 |
1988-10-19 |
Imperial Chemical Industries Plc |
Continuous release formulations
|
|
US5340926A
(en)
*
|
1983-03-25 |
1994-08-23 |
Celltech, Limited |
Process for the recovery of recombinantly produced protein from insoluble aggregate
|
|
JPS60100516A
(ja)
*
|
1983-11-04 |
1985-06-04 |
Takeda Chem Ind Ltd |
徐放型マイクロカプセルの製造法
|
|
US5332805A
(en)
*
|
1984-02-03 |
1994-07-26 |
Celltech Limited |
Process for the recovery of recombinantly produced chymosin from insoluble aggregate
|
|
US5128326A
(en)
*
|
1984-12-06 |
1992-07-07 |
Biomatrix, Inc. |
Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
|
|
FR2590674B1
(fr)
*
|
1985-11-25 |
1989-03-03 |
Inst Nat Sante Rech Med |
Nouveaux reactifs de diagnostic
|
|
US4717766A
(en)
*
|
1986-01-27 |
1988-01-05 |
Miles Laboratories, Inc. |
Method of preparing high titer anti-respiratory syncytial virus intravenous immune globulin
|
|
US4659563A
(en)
*
|
1986-01-27 |
1987-04-21 |
Miles Laboratories, Inc. |
High titer anti-respiratory syncytial virus intravenous immune globulin
|
|
JP3101690B2
(ja)
*
|
1987-03-18 |
2000-10-23 |
エス・ビィ・２・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
US4800078A
(en)
*
|
1987-05-28 |
1989-01-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb
|
|
GB8719041D0
(en)
*
|
1987-08-12 |
1987-09-16 |
Parker D |
Conjugate compounds
|
|
GB8720833D0
(en)
*
|
1987-09-04 |
1987-10-14 |
Celltech Ltd |
Recombinant dna product
|
|
US5223254A
(en)
*
|
1987-09-29 |
1993-06-29 |
Praxis Biologics, Inc. |
Respiratory syncytial virus: vaccines
|
|
WO1989005823A1
(en)
*
|
1987-12-23 |
1989-06-29 |
The Upjohn Company |
Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus
|
|
US5183657A
(en)
*
|
1988-03-11 |
1993-02-02 |
Celltech Limited |
Antibodies for use in antilymphocyte antibody therapy
|
|
US5137804A
(en)
*
|
1988-05-10 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
Assay device and immunoassay
|
|
US5223409A
(en)
*
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5530101A
(en)
*
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5332567A
(en)
*
|
1989-08-24 |
1994-07-26 |
Immunomedics |
Detection and treatment of infections with immunoconjugates
|
|
US5518725A
(en)
*
|
1989-09-25 |
1996-05-21 |
University Of Utah Research Foundation |
Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
|
|
CA2071867A1
(en)
*
|
1989-11-06 |
1991-05-07 |
Edith Mathiowitz |
Method for producing protein microspheres
|
|
GB8928874D0
(en)
*
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
US5279935A
(en)
*
|
1990-03-01 |
1994-01-18 |
Becton, Dickinson And Company |
Method of immunossay including deactivation of endogenous alkaline phosphatase
|
|
JPH04507109A
(ja)
*
|
1990-05-03 |
1992-12-10 |
システミックス インコーポレイテッド |
免疫無防備状態宿主中におけるヒトリンパ球組織
|
|
EP0581882B1
(en)
*
|
1991-04-22 |
1998-01-07 |
Massachusetts Health Research Institute, Inc. (Mhri) |
Process of screening plasma samples for effective antibody titers against respiratory viruses
|
|
JPH06507404A
(ja)
*
|
1991-05-01 |
1994-08-25 |
ヘンリー エム．ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン |
感染性の呼吸性疾患の治療方法
|
|
US5240694A
(en)
*
|
1991-09-23 |
1993-08-31 |
University Of Virginia |
Combined antiviral and antimediator treatment of common colds
|
|
US5418136A
(en)
*
|
1991-10-01 |
1995-05-23 |
Biostar, Inc. |
Devices for detection of an analyte based upon light interference
|
|
DE69224651T2
(de)
*
|
1991-11-15 |
1998-07-23 |
Cornell Res Foundation Inc |
Indirekter immunoassay für dioxinähnliche verbindungen
|
|
US20020102257A1
(en)
*
|
1998-09-21 |
2002-08-01 |
Leslie Sid Johnson |
Human-murine chimeric antibodies against respiratory syncytial virus
|
|
US5824307A
(en)
*
|
1991-12-23 |
1998-10-20 |
Medimmune, Inc. |
Human-murine chimeric antibodies against respiratory syncytial virus
|
|
US5667988A
(en)
*
|
1992-01-27 |
1997-09-16 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
|
US5912015A
(en)
*
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
|
AU686113B2
(en)
*
|
1992-09-16 |
1998-02-05 |
Scripps Research Institute, The |
Human neutralizing monoclonal antibodies to respiratory syncytial virus
|
|
US6685942B1
(en)
*
|
1993-12-10 |
2004-02-03 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to respiratory syncytial virus
|
|
EP0680337A4
(en)
*
|
1993-01-12 |
1997-07-30 |
Anthony George Gristina |
METHODS AND COMPOSITIONS FOR DIRECT APPLICATION WITH HIGH CONCENTRATION OF ANTIBODIES, PRODUCING PASSIVE IMMUNITY.
|
|
US5934272A
(en)
*
|
1993-01-29 |
1999-08-10 |
Aradigm Corporation |
Device and method of creating aerosolized mist of respiratory drug
|
|
US5424189A
(en)
*
|
1993-03-05 |
1995-06-13 |
Kansas State University Research Foundation |
Bovine respiratory syncytial virus detection and primers
|
|
NZ269735A
(en)
*
|
1993-07-30 |
1998-01-26 |
Oravax Inc |
Monoclonal iga antibody against respiratory syncytial virus (rsv)
|
|
US5538952A
(en)
*
|
1994-05-26 |
1996-07-23 |
Abbott Laboratories |
Inhibition of infection of mammalian cells by respiratory syncytial virus
|
|
US5506209A
(en)
*
|
1994-05-26 |
1996-04-09 |
Abbott Laboratories |
Product for inhibition of infection of mammalian cells by respiratory syncytial virus
|
|
US5538733A
(en)
*
|
1994-07-07 |
1996-07-23 |
Willmar Poultry Company, Inc. |
Method of priming an immune response in a one-day old animal
|
|
US6019968A
(en)
*
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
|
US5869046A
(en)
*
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
US5747035A
(en)
*
|
1995-04-14 |
1998-05-05 |
Genentech, Inc. |
Polypeptides with increased half-life for use in treating disorders involving the LFA-1 receptor
|
|
US6121022A
(en)
*
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
US5739277A
(en)
*
|
1995-04-14 |
1998-04-14 |
Genentech Inc. |
Altered polypeptides with increased half-life
|
|
US5811524A
(en)
*
|
1995-06-07 |
1998-09-22 |
Idec Pharmaceuticals Corporation |
Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
|
|
AU710347B2
(en)
*
|
1995-08-31 |
1999-09-16 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
|
ES2148799T3
(es)
*
|
1995-09-18 |
2000-10-16 |
Intracel Corp |
Anticuerpos monoclonales neutralizantes contra virus sincitial respiratorio.
|
|
US5985320A
(en)
*
|
1996-03-04 |
1999-11-16 |
The Penn State Research Foundation |
Materials and methods for enhancing cellular internalization
|
|
US5874064A
(en)
*
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US5985309A
(en)
*
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
|
US5855913A
(en)
*
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
US6117980A
(en)
*
|
1997-02-21 |
2000-09-12 |
Genentech, Inc. |
Humanized anti-IL-8 monoclonal antibodies
|
|
US6277375B1
(en)
*
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
|
US6069551A
(en)
*
|
1997-05-02 |
2000-05-30 |
Therm-O-Disc, Incorporated |
Thermal switch assembly
|
|
US5989463A
(en)
*
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
|
US6194551B1
(en)
*
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
US6528624B1
(en)
*
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
|
US6572856B1
(en)
*
|
1998-09-10 |
2003-06-03 |
The University Of Virginia Patent Foundation |
Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies
|
|
US6737056B1
(en)
*
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
US7149773B2
(en)
*
|
1999-07-07 |
2006-12-12 |
Medtronic, Inc. |
System and method of automated invoicing for communications between an implantable medical device and a remote computer system or health care provider
|
|
AU2002219944B2
(en)
*
|
2000-11-28 |
2008-02-21 |
Medimmune, Llc |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
US7229619B1
(en)
*
|
2000-11-28 |
2007-06-12 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
CA2398466A1
(en)
*
|
2000-01-27 |
2001-08-02 |
Medimmune, Inc. |
Ultra high affinity neutralizing antibodies
|
|
US20010034062A1
(en)
*
|
2000-02-09 |
2001-10-25 |
Scott Koenig |
Antibody gene therapy with adeno-associated viral vectors
|
|
JP2003525061A
(ja)
*
|
2000-03-01 |
2003-08-26 |
メディミューン，インコーポレイテッド |
高効力組換え抗体およびその産生法
|
|
AU2001241918A1
(en)
*
|
2000-03-02 |
2001-09-12 |
Med Immune, Inc. |
Methods of enhancing activity of vaccines and vaccine compositions
|
|
AU5345901A
(en)
*
|
2000-04-13 |
2001-10-30 |
Univ Rockefeller |
Enhancement of antibody-mediated immune responses
|
|
EP1152199B1
(de)
*
|
2000-05-03 |
2005-07-27 |
IPV Inheidener Produktions- und Vertriebsgesellschaft mbH |
Thermobehälter
|
|
CA2407292A1
(en)
*
|
2000-05-03 |
2001-11-08 |
Medimmune, Inc. |
Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
|
|
JP2003531866A
(ja)
*
|
2000-05-03 |
2003-10-28 |
メディミューン，インコーポレイテッド |
抗体を用いた呼吸器疾患の組合せ治療法
|
|
US20020018780A1
(en)
*
|
2000-05-25 |
2002-02-14 |
Scott Koenig |
Epitope-based vaccine for respiratory syncytial virus F-protein
|
|
AU2001276737A1
(en)
*
|
2000-08-04 |
2002-02-18 |
Chugai Seiyaku Kabushiki Kaisha |
Protein injection preparations
|
|
US6565888B1
(en)
*
|
2000-08-23 |
2003-05-20 |
Alkermes Controlled Therapeutics, Inc. |
Methods and compositions for the targeted delivery of biologically active agents
|
|
US6818216B2
(en)
*
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
|
US6855493B2
(en)
*
|
2000-11-28 |
2005-02-15 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
US7179900B2
(en)
*
|
2000-11-28 |
2007-02-20 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
|
EP1355919B1
(en)
*
|
2000-12-12 |
2010-11-24 |
MedImmune, LLC |
Molecules with extended half-lives, compositions and uses thereof
|
|
US7658921B2
(en)
*
|
2000-12-12 |
2010-02-09 |
Medimmune, Llc |
Molecules with extended half-lives, compositions and uses thereof
|
|
US20040096451A1
(en)
*
|
2002-07-25 |
2004-05-20 |
Young James F. |
Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
|
|
US20040002587A1
(en)
*
|
2002-02-20 |
2004-01-01 |
Watkins Jeffry D. |
Fc region variants
|
|
US7132100B2
(en)
*
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
|
US7425618B2
(en)
*
|
2002-06-14 |
2008-09-16 |
Medimmune, Inc. |
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
|
|
US7365168B2
(en)
*
|
2002-10-15 |
2008-04-29 |
Pdl Biopharma, Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
|
US7361740B2
(en)
*
|
2002-10-15 |
2008-04-22 |
Pdl Biopharma, Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
|
US7217797B2
(en)
*
|
2002-10-15 |
2007-05-15 |
Pdl Biopharma, Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
|
EP1673395A1
(en)
*
|
2003-10-15 |
2006-06-28 |
PDL BioPharma, Inc. |
Alteration of fc-fusion protein serum half-lives by mutagenesis of positions 250, 314 and/or 428 of the heavy chain constant region of ig
|
|
JP2008513540A
(ja)
*
|
2004-09-21 |
2008-05-01 |
メディミューン，インコーポレーテッド |
呼吸器合胞体ウイルスに対する抗体及び該ウイルス用のワクチンを製造する方法
|
|
CA2585891A1
(en)
*
|
2004-10-29 |
2006-05-11 |
Medimmune, Inc. |
Methods of preventing and treating rsv infections and related conditions
|
|
US8568726B2
(en)
*
|
2009-10-06 |
2013-10-29 |
Medimmune Limited |
RSV specific binding molecule
|